The role of human dendritic cells in HIV-1 infection

Journal of Investigative Dermatology

Volumn 135, Issue 5, 2015, Pages 1225-1233

  Ahmed, Zahra ^a   Kawamura, Tatsuyoshi ^b   Shimada, Shinji ^b   Piguet, Vincent ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DENDRITIC CELL; DERMIS; DISEASE PREDISPOSITION; EPIDERMIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LANGERHANS CELL; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS CELL INTERACTION; CELL COMMUNICATION; HIV INFECTIONS; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSMISSION;

VIRUS VACCINE;

CELL COMMUNICATION; DENDRITIC CELLS; HIV INFECTIONS; HIV-1; HUMANS; LANGERHANS CELLS; VIRAL VACCINES;

EID: 84928437032     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.490     Document Type: Review

References (129)

1. Abdool Karim Q, Abdool Karim SS, Frohlich JA et al. (2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329:1168-74
2. Ablasser A, Goldeck M, Cavlar T et al. (2013) cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING. Nature 498:380-4
3. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783-801
4. Altfeld M, Fadda L, Frleta D et al. (2011) DCs and NK cells: critical effectors in the immune response to HIV-1. Nat Rev Immunol 11:176-86
5. Andrews CD, Spreen WR, Mohri H et al. (2014) Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus. Science 343:1151-4
6. Arrighi JF, Pion M, Garcia E et al. (2004) DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J Exp Med 200:1279-88
7. Ballweber L, Robinson B, Kreger A et al. (2011) Vaginal langerhans cells nonproductively transporting HIV-1 mediate infection of T cells. J Virol 85:13443-7
8. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245-52
9. Barber GN (2011) Cytoplasmic DNA innate immune pathways. Immunol Rev 243:99-108
10. Battivelli E, Migraine J, Lecossier D et al. (2011) Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms. J Virol 85:7828-35
11. Berger G, Durand S, Fargier G et al. (2011) APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathog 7:e1002221
12. Blanchet FP, Moris A, Nikolic DS et al. (2010) Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity 32:654-69
13. Blanchet FP, Stalder R, Czubala M et al. (2013) TLR-4 engagement of dendritic cells confers a BST- 2/tetherin-mediated restriction of HIV-1 infection to CD4+ T cells across the virological synapse. Retrovirology 10:6
14. Bloch N, O'Brien M, Norton TD et al. (2013) HIV Type 1 infection of plasmacytoid and myeloid dendritic cells is restricted by high levels of SAMHD1 and cannot be counteracted by Vpx. AIDS Res Hum Retroviruses 30:195-203
15. Brenchley JM, Schacker TW, Ruff LE et al. (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200:749-59
16. Cavrois M, Neidleman J, Kreisberg JF et al. (2007) In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions. PLoS Pathog 3:e4
17. Choudhuri K, Llodra J, Roth EW et al. (2014) Polarized release of T-cellreceptor- enriched microvesicles at the immunological synapse. Nature 507:118-23
18. Chu CC, Ali N, Karagiannis P et al. (2012) Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. J Exp Med 209:935-45
19. Coleman CM, Spearman P, Wu L (2011) Tetherin does not significantly restrict dendritic cell- mediated HIV-1 transmission and its expression is upregulated by newly synthesized HIV-1 Nef. Retrovirology 8:26
20. Cottrell ML, Kashuba AD (2014) Topical microbicides and HIV prevention in the female genital tract. J Clin Pharmacol 54:603-15
21. Cunningham AL, Carbone F, Geijtenbeek TB (2008) Langerhans cells and viral immunity. Eur J Immunol 38:2377-85
22. de Jong MA, de Witte L, Oudhoff MJ et al. (2008) TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo. J Clin Invest 118:3440-52
23. de Jong MA, de Witte L, Taylor ME et al. (2010a) Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function. J Immunol 185:1633-41
24. de Jong MA, Vriend LE, Theelen B et al. (2010b) C-type lectin Langerin is a beta-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi. Mol Immunol 47:1216-25
25. de Witte L, Bobardt M, Chatterji U et al. (2007a) Syndecan-3 is a dendritic cellspecific attachment receptor for HIV-1. Proc Natl Acad Sci USA 104:19464-9
26. de Witte L, Nabatov A, Pion M et al. (2007b) Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 13:367-71
27. Dong C, Janas AM, Wang JH et al. (2007) Characterization of human immunodeficiency virus type 1 replication in immature and mature dendritic cells reveals dissociable cis- and trans-infection. J Virol 81:11352-62
28. Engering A, Geijtenbeek TB, van Vliet SJ et al. (2002) The dendritic cellspecific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol 168:2118-26
29. Fahrbach KM, Barry SM, Ayehunie S et al. (2007) Activated CD34-derived Langerhans cells mediate transinfection with human immunodeficiency virus. J Virol 81:6858-68
30. Felts RL, Narayan K, Estes JD et al. (2010) 3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells. Proc Natl Acad Sci USA 107:13336-41
31. Ganor Y, Drillet-Dangeard AS, Lopalco L et al. (2013) Calcitonin gene-related peptide inhibits Langerhans cell-mediated HIV-1 transmission. J Exp Med 210:2161-70
32. Ganor Y, Zhou Z, Tudor D et al. (2010) Within 1h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates. Mucosal Immunol 3:506-22
33. Gao D, Wu J, Wu YT et al. (2013a) Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341:903-6
34. Gao P, Ascano M, Wu Y et al. (2013b) Cyclic [G(2', 5')pA(3', 5')p] is the metazoan second messenger produced by DNA-activated cyclic GMPAMP synthase. Cell 153:1094-107
35. Garcia E, Nikolic DS, Piguet V (2008) HIV-1 replication in dendritic cells occurs through a tetraspanin- containing compartment enriched in AP-3. Traffic 9:200-14
36. Garcia E, Pion M, Pelchen-Matthews A et al. (2005) HIV-1 trafficking to the dendritic cell-T-cell infectious synapse uses a pathway of tetraspanin sorting to the immunological synapse. Traffic 6:488-501
37. Geijtenbeek TB, Kwon DS, Torensma R et al. (2000) DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100:587-97
38. Goldstone DC, Ennis-Adeniran V, Hedden JJ et al. (2011) HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480:379-82
39. Goujon C, Moncorge O, Bauby H et al. (2013) Human MX2 is an interferoninduced post-entry inhibitor of HIV-1 infection. Nature 502:559-62
40. Granelli-Piperno A, Shimeliovich I, Pack M et al. (2006) HIV-1 selectively infects a subset of nonmaturing BDCA1-positive dendritic cells in human blood. J Immunol 176:991-8
41. Gringhuis SI, van der Vlist M, van den Berg LM et al. (2010) HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat Immunol 11:419-26
42. Groot F, van Capel TM, Kapsenberg ML et al. (2006) Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition. Blood 108:1957-64
43. Gummuluru S, Rogel M, Stamatatos L et al. (2003) Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway. J Virol 77:12865-74
44. Haase AT (2010) Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464:217-23
45. Haniffa M, Shin A, Bigley V et al. (2012) Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 37:60-73
46. Harman AN, Bye CR, Nasr N et al. (2013a) Identification of lineage relationships and novel markers of blood and skin human dendritic cells. J Immunol 190:66-79
47. Harman AN, Kim M, Nasr N et al. (2013b) Tissue dendritic cells as portals for HIV entry. Rev Med Virol 23:319-33
48. Harris A, Borgnia MJ, Shi D et al. (2011) Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures. Proc Natl Acad Sci USA 108:11440-5
49. Hatch SC, Archer J, Gummuluru S (2009) Glycosphingolipid composition of human immunodeficiency virus type 1 (HIV-1) particles is a crucial determinant for dendritic cell-mediated HIV-1 trans- infection. J Virol 83:3496-506
50. Haynes BF, Gilbert PB, McElrath MJ et al. (2012) Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med 366:1275-86
51. Hladik F, Sakchalathorn P, Ballweber L et al. (2007) Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26:257-70
52. Hrecka K, Hao C, Gierszewska M et al. (2011) Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474:658-61
53. Hu J, Gardner MB, Miller CJ (2000) Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol 74:6087-95
54. Iwasaki A (2012) Innate immune recognition of HIV-1. Immunity 37:389-98
55. Izquierdo-Useros N, Blanco J, Erkizia I et al. (2007) Maturation of bloodderived dendritic cells enhances human immunodeficiency virus type 1 capture and transmission. J Virol 81:7559-70
56. Izquierdo-Useros N, Naranjo-Gomez M, Archer J et al. (2009) Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood 113:2732-41
57. Kane M, Yadav SS, Bitzegeio J et al. (2013) MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502:563-6
58. Kawamura T, Cohen SS, Borris DL et al. (2000) Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J Exp Med 192:1491-500
59. Kawamura T, Gulden FO, Sugaya M et al. (2003) R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms. Proc Natl Acad Sci USA 100:8401-6
60. Kawamura T, Qualbani M, Thomas EK et al. (2001) Low levels of productive HIV infection in Langerhans cell-like dendritic cells differentiated in the presence of TGF-beta1 and increased viral replication with CD40 ligandinduced maturation. Eur J Immunol 31:360-8
61. Kirchhoff F (2010) Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8:55-67
62. Laguette N, Benkirane M (2012) How SAMHD1 changes our view of viral restriction. Trends Immunol 33:26-33
63. Laguette N, Sobhian B, Casartelli N et al. (2011) SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474:654-7
64. Lahaye X, Satoh T, Gentili M et al. (2013) The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 39:1132-42
65. Lahouassa H, Daddacha W, Hofmann H et al. (2012) SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 13:223-8
66. Lambert AA, Barabe F, Gilbert C et al. (2011) DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway. Blood 117:6589-99
67. Lambert AA, Gilbert C, Richard M et al. (2008) The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways. Blood 112:1299-307
68. Lederman MM, Veazey RS, Offord R et al. (2004) Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 306:485-7
69. Lenz A, Heine M, Schuler G et al. (1993) Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J Clin Invest 92:2587-96
70. Li M, Kao E, Gao X et al. (2012) Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11. Nature 491:125-8
71. Li Q, Duan L, Estes JD et al. (2005) Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434:1148-52
72. Liu YJ (2001) Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106:259-62
73. Manches O, Fernandez MV, Plumas J et al. (2012) Activation of the noncanonical NF-kappaB pathway by HIV controls a dendritic cell immunoregulatory phenotype. Proc Natl Acad Sci USA 109:14122-7
74. Manches O, Frleta D, Bhardwaj N (2014) Dendritic cells in progression and pathology of HIV infection. Trends Immunol 35:114-22
75. Manel N, Hogstad B, Wang Y et al. (2010) A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467:214-7
76. Matsuzawa T, Kawamura T, Ogawa Y et al. (2014) EFdA, a reverse transcriptase inhibitor, potently blocks HIV-1 ex vivo infection of Langerhans cells within epithelium. J Invest Dermatol 134:1158-61
77. Matsuzawa T, Kawamura T, Ogawa Y et al. (2013) Oral administration of the CCR5 inhibitor, maraviroc, blocks HIV ex vivo infection of Langerhans cells within the epithelium. J Invest Dermatol 133:2803-5
78. Mattapallil JJ, Douek DC, Hill B et al. (2005) Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434:1093-7
79. McDonald D, Wu L, Bohks SM et al. (2003) Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300:1295-7
80. Mehandru S, Poles MA, Tenner-Racz K et al. (2004) Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 200:761-70
81. Meylan PR, Guatelli JC, Munis JR et al. (1993) Mechanisms for the inhibition of HIV replication by interferons-alpha, -beta, and -gamma in primary human macrophages. Virology 193:138-48
82. Mohanram V, Skold AE, Bachle SM et al. (2013) IFN-alpha induces APOBEC3G, F, and A in immature dendritic cells and limits HIV-1 spread to CD4+ T cells. J Immunol 190:3346-53
83. Moris A, Pajot A, Blanchet F et al. (2006) Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer. Blood 108:1643-51
84. Murooka TT, Deruaz M, Marangoni F et al. (2012) HIV-infected T cells are migratory vehicles for viral dissemination. Nature 490:283-7
85. Nestle FO, Zheng XG, Thompson CB et al. (1993) Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol 151:6535-45
86. Nikolic DS, Lehmann M, Felts R et al. (2011) HIV-1 activates Cdc42 and induces membrane extensions in immature dendritic cells to facilitate cell-to-cell virus propagation. Blood 118:4841-52
87. Nobile C, Petit C, Moris A et al. (2005) Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J Virol 79:5386-99
88. O'Brien M, Manches O, Sabado RL et al. (2011) Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-alphaproducing and partially matured phenotype. J Clin Invest 121:1088-101
89. Ogawa Y, Kawamura T, Kimura T et al. (2009) Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation. Blood 113:5157-66
90. Ogawa Y, Kawamura T, Matsuzawa T et al. (2013) Antimicrobial peptide LL-37 produced by HSV-2- infected keratinocytes enhances HIV infection of Langerhans cells. Cell Host Microbe 13:77-86
91. Pavli P, Hume DA, Van De Pol E et al. (1993) Dendritic cells, the major antigen-presenting cells of the human colonic lamina propria. Immunology 78:132-41
92. Pelchen-Matthews A, Kramer B, Marsh M (2003) Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol 162:443-55
93. Peressin M, Proust A, Schmidt S et al. (2014) Efficient transfer of HIV-1 in trans and in cis from Langerhans dendritic cells and macrophages to autologous T lymphocytes. AIDS 28:667-77
94. Pertel T, Hausmann S, Morger D et al. (2011) TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472:361-5
95. Piguet V, Steinman RM (2007) The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol 28:503-10
96. Pion M, Arrighi JF, Jiang J et al. (2007) Analysis of HIV-1-X4 fusion with immature dendritic cells identifies a specific restriction that is independent of CXCR4 levels. J Invest Dermatol 127:319-23
97. Pion M, Granelli-Piperno A, Mangeat B et al. (2006) APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection. J Exp Med 203:2887-93
98. Pollara J, Bonsignori M, Moody MA et al. (2014) HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities. J Virol 88:7715-26
99. Popov S, Chenine AL, Gruber A et al. (2005) Long-term productive human immunodeficiency virus infection of CD1a-sorted myeloid dendritic cells. J Virol 79:602-8
100. Puryear WB, Akiyama H, Geer SD et al. (2013) Interferon-inducible mechanism of dendritic cell- mediated HIV-1 dissemination is dependent on Siglec-1/CD169. PLoS Pathog 9:e1003291
101. Rasaiyaah J, Tan CP, Fletcher AJ et al. (2013) HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 503:402-5
102. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S et al. (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361:2209-20
103. Romani N, Brunner PM, Stingl G (2012) Changing views of the role of Langerhans cells. J Invest Dermatol 132:872-81
104. Sandgren KJ, Smed-Sorensen A, Forsell MN et al. (2013) Human plasmacytoid dendritic cells efficiently capture HIV-1 envelope glycoproteins via CD4 for antigen presentation. J Immunol 191:60-9
105. Santini SM, Lapenta C, Logozzi M et al. (2000) Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med 191:1777-88
106. Schaller T, Ocwieja KE, Rasaiyaah J et al. (2011) HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog 7:e1002439
107. Schmidt B, Ashlock BM, Foster H et al. (2005) HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration. Virology 343:256-66
108. Sheehy AM, Gaddis NC, Malim MH (2003) The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9:1404-7
109. Shoji-Kawata S, Sumpter R, Leveno M et al. (2013) Identification of a candidate therapeutic autophagy-inducing peptide. Nature 494:201-6
110. Smed-Sorensen A, Lore K, Vasudevan J et al. (2005) Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells. J Virol 79:8861-9
111. Stacey AR, Norris PJ, Qin L et al. (2009) Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 83:3719-33
112. Steinman RM (2012) Decisions about dendritic cells: past, present, and future. Annu Rev Immunol 30:1-22
113. Steinman RM, Banchereau J (2007) Taking dendritic cells into medicine. Nature 449:419-26
114. Steinman RM, Cohn ZA (1973) Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137:1142-62
115. Stetson DB, Ko JS, Heidmann T et al. (2008) Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134:587-98
116. Sun L, Wu J, Du F et al. (2013) Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339:786-91
117. Trumpfheller C, Park CG, Finke J et al. (2003) Cell type-dependent retention and transmission of HIV-1 by DC-SIGN. Int Immunol 15:289-98
118. Turville S, Wilkinson J, Cameron P et al. (2003) The role of dendritic cell C-type lectin receptors in HIV pathogenesis. J Leukoc Biol 74:710-8
119. Turville SG, Cameron PU, Handley A et al. (2002) Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol 3:975-83
120. Turville SG, Santos JJ, Frank I et al. (2004) Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 103:2170-9
121. Valladeau J, Duvert-Frances V, Pin JJ et al. (1999) The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol 29:2695-704
122. Valladeau J, Ravel O, Dezutter-Dambuyant C et al. (2000) Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12:71-81
123. van den Berg LM, Geijtenbeek TB (2013) Antiviral immune responses by human langerhans cells and dendritic cells in HIV-1 infection. Adv Exp Med Biol 762:45-70
124. Veazey RS, Klasse PJ, Schader SM et al. (2005) Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 438:99-102
125. White TE, Brandariz-Nunez A, Valle-Casuso JC et al. (2013) The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. Cell Host Microbe 13:441-51
126. Wu L, KewalRamani VN (2006) Dendritic-cell interactions with HIV: infection and viral dissemination. Nat Rev Immunol 6:859-68
127. Yan N, Regalado-Magdos AD, Stiggelbout B et al. (2010) The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat Immunol 11:1005-13
128. Zhang X, Shi H, Wu J et al. (2013) Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell 51:226-35
129. Zhou Z, Barry de Longchamps N, Schmitt A et al. (2011) HIV-1 efficient entry in inner foreskin is mediated by elevated CCL5/RANTES that recruits T cells and fuels conjugate formation with Langerhans cells. PLoS Pathog 7:e1002100